Export restrictions stemming from the US-China trade conflict significantly undermine biomedical research in China, disrupting key projects in cell therapy and molecular diagnostics.
The Cell Therapy Launch Facility at Bayer's Berkeley campus is the first industrial manufacturing facility in the western US to achieve LEED Platinum certification.